- People will be safe at 118th Boston Marathon, Mayor Marty Walsh says
- Boy Scout, 12, killed by rolling tree during troop outing at Washington park
- South Korean president: Ferry crew actions ‘murderous’
- President Obama poised to grant clemency to nonviolent drug offenders: report
- Teen OK after riding in wheel well of Hawaii jet
- Kraft recalls 96K pounds of Oscar Mayer hot dogs over cheese error
- Boy Scouts boots church as host after gay leadership dispute
- Sen. Elizabeth Warren’s new book raises 2016 presidential speculation
- America is an oligarchy, not a democracy or republic, university study finds
- Rep. Marsha Blackburn: Hillary Clinton won’t be first female president
Medicine agency: Roche did not report side effects
LONDON (AP) - The European Medicines Agency is investigating “deficiencies” in the way drug maker Roche reported possible side effects in patients in the U.S., though it said there was no evidence patients are at risk.
European authorities spotted the problems during a routine inspection of Roche by British regulators in May. They noticed about 80,000 reports of possible side effects for medicines sold in the U.S. had not been analyzed to see if they were truly suspected adverse effects that needed to be reported. The reports were collected in a patient program that helps people deal with health insurance issues in the U.S., like reimbursement for medicines. Dozens of drugs were involved, including many cancer drugs.
“The scale of it sounds big, but what is not known is how many of these deaths have already been reported in another way,” said Monika Benstetter, an EMA spokeswoman. “We need to get to the bottom of this.”
Drug agencies regularly track side effects of drugs on the market since rare adverse events might not have been picked up during clinical trials when only limited numbers of people are exposed to the medicines.
Roche AG acknowledged it did not fully comply with regulations on the reporting system and that it was working “to address this matter expeditiously.” Possible side effects picked up by the patient support program were not sent to Roche’s own database for evaluation and therefore never made it to health officials, according to spokesman Daniel Grotzky. He said both minor and serious side effects were reported but could not provide further details.
“This was not intentional but of course it’s not something that should have happened,” Grotzky said. “We’re looking into all of these cases and we will work with health authorities to update them.” He said preliminary numbers had been given to health authorities about the potential number of missed adverse events and that measures would be taken to update their database. Grotzky said they hoped to have final numbers by January.
“Based on the information we have, there is no need for patients to change their treatment,” Benstetter said. “But we need more evidence that these deficiencies are being addressed.”
TWT Video Picks
Women losing coverage under Obamacare, too
- Tactical advantage: Russian military shows off impressive new gear
- Former Ranger breaks silence on Pat Tillman death: I may have killed him
- Scalia to students on high taxes: At a certain point, 'perhaps you should revolt'
- Special Forces' suicide rates hit record levels casualties of 'hard combat'
- USAID documents cite Hillary Clinton in chaos of Afghan aid
- CURL: Shelly O first lady Michelle Obama comes in last
- Feds approve powdered alcohol; 'Palcohol' available later this year
- Twitter blocks accounts critical of Turkish government
- Inside China: Marine's comment on islands draws sharp Chinese response
- Building a D.C. memorial for an endless war bumps into regulations
Top 10 handguns in the U.S.